[go: up one dir, main page]

TW201313726A - 製造合成之中間體之方法 - Google Patents

製造合成之中間體之方法 Download PDF

Info

Publication number
TW201313726A
TW201313726A TW101133871A TW101133871A TW201313726A TW 201313726 A TW201313726 A TW 201313726A TW 101133871 A TW101133871 A TW 101133871A TW 101133871 A TW101133871 A TW 101133871A TW 201313726 A TW201313726 A TW 201313726A
Authority
TW
Taiwan
Prior art keywords
compound
formula
polar aprotic
mixture
aprotic solvent
Prior art date
Application number
TW101133871A
Other languages
English (en)
Chinese (zh)
Inventor
Stefan Abele
Eike J Bergner
Christian Bukovec
Jacques-Alexis Funel
Christian Hubschwerlen
Azely Mirre
Ivan Schindelholz
Jean-Philippe Surivet
Acklin Cornelia Zumbrunn
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of TW201313726A publication Critical patent/TW201313726A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW101133871A 2011-09-16 2012-09-14 製造合成之中間體之方法 TW201313726A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2011054061 2011-09-16

Publications (1)

Publication Number Publication Date
TW201313726A true TW201313726A (zh) 2013-04-01

Family

ID=47080755

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101133871A TW201313726A (zh) 2011-09-16 2012-09-14 製造合成之中間體之方法

Country Status (3)

Country Link
AR (1) AR087875A1 (fr)
TW (1) TW201313726A (fr)
WO (1) WO2013038374A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202100526A (zh) 2019-03-06 2021-01-01 日商第一三共股份有限公司 吡咯并吡唑衍生物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2340531T3 (es) 2005-10-21 2010-06-04 Glaxo Group Limited Compuestos triciclos peri-condensados utiles como agentes antibacterianos.
US7732460B2 (en) 2005-12-22 2010-06-08 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (fr) 2007-05-18 2008-11-19 Glaxo Group Limited Dérivés et analogues de N-éthylquinolones et N-éthylazaquinolones
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP1980251A1 (fr) 2007-04-13 2008-10-15 Glaxo Group Limited Derivées de pyrrolo[3,2,1-ij]quinoline-4-one pour traiter la tuberculose
ES1065649Y (es) 2007-06-22 2008-01-01 Gavalda Josep Sarmiento Disposicion perfeccionada de apertura de bozal para animales
WO2009128953A2 (fr) 2008-04-18 2009-10-22 University Of Maryland, Baltimore Variants génétiques dans un gène stk39 de susceptibilité à l’hypertension et leurs utilisations
AU2009325902B2 (en) 2008-12-12 2015-01-29 Idorsia Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
AR087875A1 (es) 2014-04-23
WO2013038374A1 (fr) 2013-03-21

Similar Documents

Publication Publication Date Title
RS57569B1 (sr) Postupci za pripremanje agensa koji uzrokuje apoptozu
KR102684954B1 (ko) 아미노피리미딘 유도체의 합성에 유용한 신규의 중간체, 이의 제조방법 및 이를 이용한 아미노피리미딘 유도체의 제조방법
RS64545B1 (sr) Postupak za pripremu n-(5-(4-(4-formil-3-fenil-1h-pirazol-1-il)pirimidin-2-ilamino)-4-metoksi-2-morfolinofenil)akrilamida
CN113880834B (zh) N-(苯基磺酰基)苯甲酰胺类化合物及其中间体的合成方法
JP6513105B2 (ja) トリアジン、ピリミジン及びピリジン誘導体の新規製造方法
CA3126738A1 (fr) Procede de preparation de compose morpholinquinazoline et de corps median associe
CA2652397A1 (fr) Methode de preparation de beta-aminocarboxamides cycliques chiraux
TW202216723A (zh) 用於抑制shp2活性的化合物及組成物之製造
CN104114556B (zh) 制造萘啶衍生物的方法
TW201313726A (zh) 製造合成之中間體之方法
JP2024517004A (ja) Btk阻害剤を調製するための方法
JP2011168577A (ja) 2−アミノ−4−トリフルオロメチルピリジン類の製造方法
TWI432435B (zh) 作為合成中間物之噻唑基-吡唑并嘧啶化合物及相關合成方法
CA2488034C (fr) Procede de production de 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide et d'analogues
EP3419967A1 (fr) Procédés et intermédiaires de synthèse
CA3036936C (fr) Methode de production optimisee pour un agent de lutte antiparasitaire a 2-acyliminopyridine
EP3911649A1 (fr) Procédé de préparation de tétrahydropyridopyrimidines
CA3048667A1 (fr) Procedes de preparation de 6-aminoisoquinoline
KR20150006006A (ko) 나프티리딘 유도체의 제조 방법
JP2013540141A (ja) 置換n−(3−アミノ−キノキサリン−2−イル)−スルホンアミドおよびそれらの中間体n−(3−クロロ−キノキサリン−2−イル)スルホンアミドを調製する方法
EP3157907B1 (fr) Procédé pour la préparation de composés de triazolo[4,5-d]pyrimidine cyclopentane
KR20240057365A (ko) 다이메틸-2,3-다이하이드로-1h-인덴 유도체의 개선된 제조방법
KR20260003114A (ko) 4-아미노인단의 제조 방법 및 디하이드로인데닐-피라졸로[3,4-b]피리딘 아민 화합물의 제조 방법
KR20230118102A (ko) (9S)-N-[3-(6-메틸피리미딘-4-일)-3-아자비시클로[3.2.1]옥탄-8-일]-9-(2,3,4-트리플루오로페닐)-6,7,8,9-테트라히드로-5H-[1,2,4]트리아졸로[1,5-a]아제핀-2-아민 및 이의 고체 형태의 제조 방법
WO2024224297A1 (fr) Procédé de préparation de 4-aminoindane et procédé de préparation de dihydroindényl-pyrazolo[3,4-b]pyridine-amine